Earnings Call: Castle Biosciences Reports Strong Q3 Growth, Raises Guidance
Daily NewsLeading skin cancer diagnostic company Castle Biosciences Inc. (CSTL) reported a significant 39% increase in revenue, reaching $85.8 million in the third quarter ...
Read More